 Connection
Amy Shah to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications Amy Shah has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.346 |
|
|
|
-
de Ferranti SD, Teng JE, Arslanian SA, Atz AM, Brothers JA, Cartoski MJ, Freemon DR, Magge SN, Mahle WT, Mietus-Snyder M, Peterson A, Raghuveer G, Russell MW, Shah AS, Sponseller CA, Stylianou M, Trachtenberg FL, Urbina EM, Ware AL, Zachariah J, Zadokar VV, McCrindle BW. A multicenter trial to test pitavastatin calcium in youth with combined dyslipidemia of obesity: Design, implementation, challenges, and responses. Am Heart J. 2026 Apr; 294:107327.
Score: 0.172
-
Ashraf AP, Sunil B, Bamba V, Breidbart E, Brar PC, Chung S, Gupta A, Khokhar A, Kumar S, Lightbourne M, Kamboj MK, Miller RS, Patni N, Raman V, Shah AS, Wilson DP, Kohn B. Case Studies in Pediatric Lipid Disorders and Their Management. J Clin Endocrinol Metab. 2021 11 19; 106(12):3605-3620.
Score: 0.130
-
McCrindle BW, Arslanian S, Mietus-Snyder M, Urbina EM, Ware AL, Teng JE, Trachtenberg F, Russell MW, Shah AS, Cartoski M, Brothers JA, Giovanni CS, Zachariah JP, Pena S, Mahle WT, Peterson AL, Magge SN, Raghuveer G, Sharma B, Kazlova V, Sponseller CA, Freemon D, Stylianou M, de Ferranti SD. A 2-year randomized trial of pitavastatin calcium vs placebo to treat combined dyslipidemia in adolescents with overweight and obesity. J Clin Lipidol. 2026 Jun; 20(6):1212-1235.
Score: 0.044
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|